← Eichor
Condition: Recurrent Classic Hodgkin Lymphoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Classic Hodgkin Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PD-1 Inhibitors Maintenance for cHL Post-autoHCT
Phase 2 · 4 location(s) · St. Petersburg State Pavlov Medical University · NCT06812858Study of Pembrolizumab With Bendamustine in Hodgkin Lymphoma
Phase 2 · 1 location(s) · University Health Network, Toronto · NCT04510636Immunotherapy in Lymphoma
Phase N/A · 2 location(s) · Sung-Soo Park · NCT06796517Brentuximab Vedotin and Nivolumab for the Treatment of Relapsed/Refractory Classic Hodgkin Lymphoma Previously Treated W
Phase 2 · 2 location(s) · Emory University · NCT05039073Changing Paragidms In The Prognostic Assessment Of Hodgkin Lymphoma
Phase N/A · 12 location(s) · Azienda USL Reggio Emilia - IRCCS · NCT06822855
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.